Innovative Public Access Visualization Tools in Cardiovascular Disease: Supporting Providers, Patients, and Policy Makers With EARTH-HCM
Long-Term Efficacy and Safety Outcomes for Cardiac Myosin Inhibition in Adults With Symptomatic NYHA Class II–III Obstructive HCM
